🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

719 results for “LI” Clear

  1. ulipristal

    ESMYA

    EMA: withdrawn

    G03XB02

  2. ulipristal acetate

    ELLAONE Teva Pharma GmbH

    ORAL FDA: approved · EMA: approved

    G03AD02

  3. umbralisib tosylate

    UKONIQ

    ORAL FDA: approved

  4. umeclidinium

    INCRUSE ELLIPTA GlaxoSmithKline

    EMA: approved · TGA: approved

    R03BB07

  5. umeclidinium + vilanterol

    ANORO ELLIPTA 62.5/25 GlaxoSmithKline

    TGA: approved

  6. umeclidinium bromide

    ANORO ELLIPTA (PREVIOUSLY ANORO)

    INHALATION FDA: approved · EMA: approved

    R03AL03

  7. umeclidinium bromide/ vilanterol trifenatate

    ANORO ELLIPTA

    PMDA: approved

  8. urofollitropin

    BRAVELLE

    INTRAMUSCULAR FDA: approved · NMPA: clinical trials

  9. ursodeoxycholic acid

    URSOFALK Lacuna Pharma Pty Ltd

    TGA: approved

  10. valine with carbohydrate

    VALINE 50 Talion

    TGA: approved

  11. varenicline

    PHARMACOR VARENICLINE Alphapharm Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    N07BA03

  12. varenicline tartrate

    VARENICLINE TARTRATE

    NASAL FDA: approved

  13. vaseline

    NMPA: clinical trials

  14. vedolizumab

    ENTYVIO Lacuna Pharma Pty Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

  15. vildagliptin

    GALVUS Novartis Pharmaceuticals

    EMA: approved · TGA: approved

    A10BH02

  16. vildagliptin + metformin

    ARX-VILDAGLIPTIN/METFORMIN 50/500 Novartis Pharmaceuticals

    TGA: approved

  17. vilobelimab

    GOHIBIC

    EMA: approved

    L04AJ10

  18. visilizumab

    NMPA: clinical trials

  19. vysribli

    VYSRIBLI (PREVIOUSLY DENOSUMAB INTAS)

    EMA: approved

    M05BX04

  20. water for injections, sterilised (b) (extemporaneously prepared eye drops and eye lotions)

    NULL

    TGA: approved

  21. zinc and salicylic acid paste

    NULL

    TGA: approved

  22. ziv-aflibercept

    ZALTRAP

    INJECTION FDA: approved

  23. zoliflodacin

    NUZOLVENCE

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources